Attenuated Acceleration to Leukemia after Ezh2 Loss in Nup98‐HoxD13 (NHD13) Myelodysplastic Syndrome
Open Access
- 1 August 2019
- journal article
- letter
- Published by Wiley in HemaSphere
- Vol. 3 (4) , e277
Abstract
Supplemental Digital Content is available in the textKeywords
This publication has 25 references indexed in Scilit:
- Genomic Classification and Prognosis in Acute Myeloid LeukemiaNew England Journal of Medicine, 2016
- Acute myeloid leukemia ontogeny is defined by distinct somatic mutationsBlood, 2015
- Myelodysplastic syndromesThe Lancet, 2014
- Clinical and biological implications of driver mutations in myelodysplastic syndromesBlood, 2013
- A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemiaGenes & Development, 2012
- Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasmsBlood, 2012
- Clinical Effect of Point Mutations in Myelodysplastic SyndromesNew England Journal of Medicine, 2011
- Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromesNature Genetics, 2010
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disordersNature Genetics, 2010
- EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing PluripotencyMolecular Cell, 2008